Human African trypanosomiasis (HAT), transmitted by tsetse flies, has historically infected hundreds of thousands of individuals annually in sub-Saharan Africa. Over the last decade, concerted control efforts have reduced reported cases to below 10,000 annually, bringing complete elimination within reach. A potential technology to eliminate HAT involves rendering the flies resistant to trypanosome infection. This approach can be achieved through the introduction of transgenic Sodalis symbiotic bacteria that have been modified to produce a trypanocide, and propagated via Wolbachia symbionts, which confer a reproductive advantage to the paratransgenic tsetse. However, the population dynamics of these symbionts within tsetse flies have not yet been evaluated. Specifically, the key factors that determine the effectiveness of paratransgenesis have yet to be quantified. To identify the impact of these determinants on T.b. gambiense and T.b. rhodesiense transmission, we developed a mathematical model of trypanosome transmission that incorporates tsetse and symbiont population dynamics. We found that fecundity and mortality penalties associated with Wolbachia or recombinant Sodalis colonization, probabilities of vertical transmission, and tsetse migration rates are fundamental to the feasibility of HAT elimination. For example, we determined that HAT elimination could be sustained over 25 years when Wolbachia colonization minimally impacted fecundity or mortality, and when the probability of recombinant Sodalis vertical transmission exceeded 99.9%. We also found that for a narrow range of recombinant Sodalis vertical transmission probability (99.9–90.6% for T.b. gambiense and 99.9–85.8% for T.b. rhodesiense), cumulative HAT incidence was reduced between 30% and 1% for T.b. gambiense and between 21% and 3% for T.b. rhodesiense, although elimination was not predicted. Our findings indicate that fitness and mortality penalties associated with paratransgenic symbionts, as well as tsetse migration rates, are instrumental to HAT elimination, and should be a key focus in the development of paratransgenic symbionts.
Human African trypanosomiasis, also known as sleeping sickness, is a parasitic disease transmitted by tsetse flies in sub-Saharan Africa. The disease leads to death if not treated. Recent control efforts have reduced the burden of disease from hundreds of thousands of cases per year to fewer than 10,000 cases annually. A potential strategy to completely eliminate sleeping sickness involves genetically modifying the symbiotic bacteria, which are vertically transmitted from mother to offspring, in order to investigate which factors are most important for the successful elimination of human African trypanosomiasis. We found that sleeping sickness was eliminated only when the genetically modified symbionts were successfully transmitted from mother to offspring, and did not reduce fertility or increase mortality in tsetse. We additionally identified tsetse migration rate as an important factor for sleeping sickness elimination.
Citation: Gilbert JA, Medlock J, Townsend JP, Aksoy S, Ndeffo Mbah M, Galvani AP (2016) Determinants of Human African Trypanosomiasis Elimination via Paratransgenesis. PLoS Negl Trop Dis 10(3): e0004465. https://doi.org/10.1371/journal.pntd.0004465
Editor: Justin V. Remais, University of California Berkeley, UNITED STATES
Received: July 12, 2015; Accepted: January 26, 2016; Published: March 8, 2016
Copyright: © 2016 Gilbert et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: JAG, SA, MNM, and APG were supported by the National Institute of Allergy and Infectious Diseases (1U01AI115648, http://www.niaid.nih.gov). JAG, MNM, and APG were supported by the National Institutes of Health (2U01GM087719, http://nih.gov). SA was supported by the National Institutes of Health and National Institute of Allergy and Infectious Diseases (R01AI068932, http://nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Human African trypanosomiasis (i.e. HAT or sleeping sickness) has historically infected more than 300,000 individuals annually in sub-Saharan Africa . Over the last decade, concerted control efforts have reduced the annual number of reported HAT cases to between 7,000 and 10,000 [2–4]. The vast majority of these cases result from infection with Trypanosoma brucei gambiense, which is found in West and Central Africa and causes a chronic form of the disease. The remainder of sleeping sickness cases arise from Trypansoma brucei rhodesiense infection, which is prevalent in East and South Africa and causes a more acute form of the disease. The WHO aims to eliminate HAT as a public health problem by 2020 .
Past and current HAT control efforts have focused on active surveillance, treatment of humans and animal reservoirs, and tsetse vector control. Patient-targeted strategies face many obstacles; there is no vaccine and treatment requires expensive and toxic intravenous drugs [5, 6]. Vector control strategies—including insecticide, traps, land clearing, and sterile male releases—have had some success in reducing the incidence of disease by controlling tsetse populations [5, 6]. However, to control or eliminate the disease, sustained strategies are required [5, 6]. Without such efforts, the disease reemerges, as evidenced by the tsetse and HAT resurgence that occurred in the 1980s following a lapse in control efforts . A potential technology to control HAT involves rendering tsetse flies refractory to trypanosome infection via the introduction of genetically modified symbiotic bacteria [8–10]. In this paratransgenic technique, one of the symbionts, of the genus Sodalis, is modified to produce a trypanocidal molecule , while the other, of the genus Wolbachia, confers a reproductive advantage to the paratransgenic flies via cytoplasmic incompatibility . It is Wolbachia that drives Sodalis into the tsetse population. This paratransgenic approach has the potential to be sustainable, because the recombinant symbionts are vertically propagated throughout the tsetse population from mother to offspring [8–10, 13].
Although this approach has been used to reduce the vectorial capacity of other insects including triatomine bugs (vector of Trypanosoma cruzi), sandflies (vector of Leishmania), and mosquitoes (vector of malaria), paratransgenesis has not yet been implemented in the field as an intervention for tsetse [14–19]. Both the genetic modification of Sodalis and its vertical transmission from mother to offspring have been investigated in the laboratory, as has the ability of Wolbachia to generate cytoplasmic incompatibility within tsetse . However, several questions remain around the dynamics of recombinant Sodalis and Wolbachia within the tsetse population as the intervention continues to be developed. In particular, it is not yet known if colonization with the new symbionts would impose any fitness penalties for tsetse fecundity or mortality, or how these penalties might affect HAT elimination. Furthermore, it is also not known how the migration of tsetse in and out of a targeted area—which is not yet quantified for many locations within sub-Saharan Africa—might dilute the impact of the intervention.
In a previous study, we developed a mathematical model that incorporated the population genetics of cytoplasmic incompatibility-inducing Wolbachia with the transmission dynamics of T.b. gambiense . We used this model to demonstrate the potential for Wolbachia-colonized tsetse to establish themselves in a population of wild type tsetse. We also used the model to examine the reduction in T.b. gambiense HAT that would be observed if these Wolbachia-colonized tsetse were resistant to trypanosome infection. In the current study, we expanded our mathematical model of trypanosome transmission and tsetse population dynamics to incorporate the vertical transmission of both Wolbachia and Sodalis (wild type and recombinant) symbionts, as well as transmission of both T.b. gambiense and T.b. rhodesiense. We parameterized our model using existing data from the epidemiological and entomological literature for T.b. gambiense and T.b. rhodesiense, respectively. To evaluate the contributors to HAT elimination via paratransgenesis, we assessed the prevalences of Wolbachia and recombinant Sodalis reached within the tsetse population, the changes in the reproductive number of HAT, as well as the percentage reduction in HAT cases predicted over 25 years for varying Wolbachia and recombinant Sodalis-associated fecundity and mortality penalties, vertical transmission probabilities, and tsetse migration rates.
To project the temporal dynamics of the paratransgenesis symbionts and the proportion of HAT cases over 25 years, we extended our previous model of trypanosome transmission  to include tsetse and symbiont population dynamics (Fig 1, see S1 Text for model equations). The model was parameterized to reflect T.b. gambiense or T.b. rhodesiense transmission (see Table 1 for parameter values), respectively, with two major distinctions between the trypanosome species: the infectious period of T.b. gambiense is much longer than that of T.b. rhodesiense, and the tsetse vectors of T.b gambiense have a greater preference for feeding on humans versus animals than the vector of T.b. rhodesiense. Thus, in the absence of any intervention, the prevalence of T.b gambiense within humans relative to that of T.b. rhodesiense is higher in the model, consistent with observations in sub-Saharan Africa .
Compartmental model of African trypanosomiasis transmission between hosts (human [H] or livestock [L]) and tsetse fly [V] vectors. Hosts are susceptible [S], latently infected [E], infectious [I] or recovered [R]. Vectors are susceptible [S], latently infected [E], infectious [I] or resistant [R].
In our model, susceptible human and/or animal hosts can be infected with trypanosomiasis following a bite by an infected tsetse fly. Infected hosts progress from latent to infectious stages of the disease at rates corresponding to the natural history of HAT. Hosts transition from the infectious compartment following treatment, hospitalization, or death. Tsetse flies follow similar stages of disease progression. Wild type tsetse that have recently emerged from pupae are susceptible to trypanosome infection and can only be infected during their first blood meal on an infected host . Although research has demonstrated that nutritionally deprived or older flies can be infected with trypanosomes, non-teneral flies are expected to play a minor role in the epidemiology of trypanosome transmission . Thus, we assume that flies that have not been infected during their first blood meal are no longer susceptible to trypanosome infection and proceed to the resistant compartment. The duration that tsetse are susceptible to trypanosome infection is also varied in sensitivity analysis, as described below. Infected flies progress from the latent to infectious stages at rates corresponding to the natural history of trypanosome infection in tsetse. Infected flies do not recover from infection and stay infectious for the remainder of their lives.
Tsetse population dynamics are modeled simultaneously with disease transmission. Wild type flies are colonized with wild type Sodalis but not with Wolbachia. Paratransgenic flies are colonized both with recombinant Sodalis and Wolbachia. The rates of reproduction of offspring that are colonized with Sodalis alone, Wolbachia alone, neither symbiont, or both symbionts are determined from a combination of tsetse fecundity, the extent of Wolbachia’s reproductive advantage, and the efficiency of the vertical transmission of the symbionts. Although symbiont density may vary within a tsetse host by age or mating status , our population-level model stratifies by presence or absence of symbionts within tsetse and does not account for within host variation.
Flies colonized with recombinant Sodalis are resistant to trypanosome transmission. Consequently, they do not contribute to disease transmission and are born into to the resistant vector compartment. Flies without recombinant Sodalis are born into the susceptible vector compartment and can be infected with trypanosomes at their first blood meal. Paratransgenesis is modeled by introducing into the resistant vector compartment a number of recombinant Sodalis-positive and Wolbachia-positive (i.e. paratransgenic) flies equal to 10% of the total wild type tsetse population size at the beginning of the model simulation.
Because paratransgenesis has not yet been developed for particular species of tsetse, we do not model a single species of tsetse. Model parameters that may differ among species, such as tsetse biting rates of humans and animals, are varied across ranges reported in the literature and calculated from both lab and field data for vectors of T.b. gambiense and T.b. rhodesiense (Table 1). In addition, model parameters for which precise values are not yet known, including paratransgenesis-specific parameters and migration rates, are varied across plausible ranges in the sensitivity analysis (Table 1).
Over the 25-year period of the model simulations, paratransgenic tsetse either become fixed in the population or went extinct. To reduce the reproductive number below one and sustain HAT elimination, we found that paratransgenic tsetse must become fixed at a prevalence greater than 84% for T.b. gambiense or 87% for T.b. rhodesiense. Fixation at prevalences below 84% or 87% will reduce the number of cases of T.b. gambiense or T.b. rhodesiense, respectively, but will not reduce the reproductive number below one and eliminate HAT. Thus, we used 84% and 87% paratransgenesis threshold as our criterion of HAT elimination of T.b. gambiense and T.b. rhodesiense, respectively.
We performed local sensitivity analyses on the paratransgenesis parameters to determine the biologically and epidemiologically feasible ranges (Table 1) over which HAT elimination could be achieved. When elimination was not feasible, we also considered whether a reduction in HAT incidence is achievable over the 25 year simulations. To determine which paratransgenesis parameters had the greatest influence on the percentage of human cases averted as a result of the release of paratransgenic tsetse, we performed global sensitivity analyses, including calculating the sensitivity index and partial rank correlation coefficient (PRCC). Sensitivity indices were calculated by fixing the value for the parameter of interest at a value from its distribution of likely values and the proportion of human cases averted was calculated while all other parameters were randomly sampled from their distributions of likely values . Joint distributions of likely parameter values were drawn from biologically realistic ranges (Table 1), restricting possible parameter value combinations to those that produce an R0 for trypanosomiasis greater than one, indicating sustained HAT transmission in the absence of intervention, as we know to be the case. In the presence of paratransgenic intervention, we calculated the mean and variance of human cases averted across all possible values of the parameter of interest from 1,000 simulations. We calculated the sensitivity index as the ratio of the variance of the estimate to the total variance in all estimates of the proportion of human cases averted. Sensitivity index values closer to one indicated that a variable contributed more to the uncertainty in the proportion of cases averted estimates. The proportion of HAT cases averted over 25 years was then calculated by execution of the model for each of 10,000 Latin Hypercube samples from the parameter ranges in Table 1, with a further restriction of the joint distribution of likely parameter values to those combinations that yielded an R0 for trypanosomiasis greater than one. PRCCs were calculated to evaluate the monotonicity of the relationship between each parameter sampled and the consequent proportion of HAT cases averted.
We found that the fecundity and mortality penalties associated with Wolbachia or recombinant Sodalis colonization, the probability of vertical transmission, and tsetse migration rates are fundamental to determining whether HAT elimination is achieved via paratransgenesis. Parameter thresholds determined which of three possible outcomes occurred following the release of paratransgenic tsetse: complete HAT elimination, negligible impact on HAT burden, or partial reduction in HAT cases.
Our results show that for paratransgenesis to eliminate HAT, Wolbachia must drive recombinant Sodalis into the tsetse population at a prevalence greater than 84% (for T.b. gambiense elimination) or 87% (for T.b. rhodesiense elimination), which will render enough flies resistant to trypanosome infection, thereby reducing the reproductive number for HAT below one (Figs 2A and 3A). A reproductive number less than one indicates that the spread of trypanosomiasis between flies, humans, and animals will eventually cease and the disease will be eliminated. When HAT is eliminated in this scenario, T.b. gambiense HAT 25 year cumulative incidence is reduced by 30% and T.b. rhodesiense HAT by 21% (Figs 2A and 3A).
(A) T.b. gambiense and perfect maternal transmission of recombinant Sodalis (0% vertical transmission failure), (B) T.b. gambiense and a 5% fecundity penalty for Wolbachia colonization, (C) T.b. gambiense and 5% probability of failure for maternal transmission of recombinant Sodalis, and (D) T.b. gambiense and 1% probability of failure for maternal transmission of recombinant Sodalis. S = Susceptible humans, E = Exposed humans, I = Infectious humans, R = Recovered humans, Wol + = Wolbachia-positive tsetse, Wol— = Wolbachia-negative tsetse, rec Sod + = recombinant Sodalis-positive tsetse, WT Sod + = wild type Sodalis-positive tsetse, and Sod— = Sodalis-negative tsetse.
(A) T.b. rhodesiense and perfect maternal transmission of recombinant Sodalis (0% vertical transmission failure), (B) T.b. rhodesiense and a 5% fecundity penalty for Wolbachia colonization, (C) T.b. rhodesiense and 5% probability of failure for maternal transmission of recombinant Sodalis, and (D) T.b. rhodesiense and 1% probability of failure for maternal transmission of recombinant Sodalis. S = Susceptible humans, E = Exposed humans, I = Infectious humans, R = Recovered humans, Wol + = Wolbachia-positive tsetse, Wol— = Wolbachia-negative tsetse, rec Sod + = recombinant Sodalis-positive tsetse, WT Sod + = wild type Sodalis-positive tsetse, and Sod— = Sodalis-negative tsetse.
One-way sensitivity analysis identified several parameter thresholds that directly influenced whether paratransgenesis is likely to eliminate HAT. First, for Wolbachia to become fixed in the tsetse population and for the HAT reproductive number to be reduced below one, the Wolbachia fecundity penalty must be less than 1.5% (Fig 4A; i.e. 98.5% or more offspring of Wolbachia colonized tsetse successfully mature into adults), the probability of successful vertical transmission over 93.7% (Fig 4B; i.e. 6.3% or fewer of tsetse offspring are born without Wolbachia), the mortality penalty less than 1.5% (Fig 4C; i.e. Wolbachia colonized tsetse die at a rate no more than 1.5% greater than wild type tsetse), and the tsetse migration rate in and out of the population less than 65% above baseline migration (0.0007 or 3.5 tsetse in and out of the population of 5,000 per day; Fig 4D). Second, in order for recombinant Sodalis to be driven by Wolbachia into the tsetse population at a prevalence sufficient to reduce the HAT reproductive number to below one, recombinant Sodalis colonization must have a fecundity penalty no more than 1.6% (Fig 4E; i.e. 98.4% or more offspring of recombinant Sodalis colonized tsetse mature into adults), a probability of vertical transmission success greater than 99.9% (Fig 4F; i.e. fewer than 0.1% of offspring are born without recombinant Sodalis), and a mortality penalty of recombinant Sodalis colonization no greater than 1.6% (Fig 4G; i.e. recombinant Sodalis colonized tsetse die at a rate no higher than 1.6% that of wild type tsetse).
(A) Fecundity penalty for Wolbachia infection, (B) Probability of maternal transmission failure for Wolbachia, (C) Increase in death rate (mortality penalty) due to Wolbachia infection, (D) Migration rate of tsetse, (E) Fecundity penalty for recombinant Sodalis colonization, (F) Probability of maternal transmission failure of recombinant Sodalis, and (G) Increase in death rate (mortality penalty) due to recombinant Sodalis colonization.
If the fitness penalty or migration rate parameter thresholds are exceeded, paratransgenesis will not eliminate or reduce HAT. Under these conditions, Wolbachia does not drive itself into the tsetse population and recombinant Sodalis also does not become fixed in the tsetse population (Figs 2B and 3B). Consequently, the number of tsetse colonized with recombinant Sodalis drops to zero quickly over a period of a few years, the HAT reproductive number remains above one, and the cumulative number of human or animal HAT infections is not reduced by more than a few percent. Another challenge can arise if recombinant Sodalis becomes unlinked from Wolbachia vertical transmission due to imperfect vertical transmission of recombinant Sodalis (Figs 2C and 3C). In this case, while Wolbachia becomes fixed in the tsetse population, trypanocidal recombinant Sodalis does not. Thus, the HAT reproductive number remains above one and cases are not reduced.
Local sensitivity analysis also identified parameter regions for which paratransgenesis could partially reduce HAT over 25-years without complete elimination. If the probability of recombinant Sodalis transmission failure from paratransgenic mother to offspring is greater than 0.1% but lower than 9.4% for T.b. gambiense or lower than 14.2% for T.b. rhodesiense (Fig 4F), recombinant Sodalis becomes partially, but not completely, unlinked from Wolbachia transmission (Figs 2D and 3D). In this parameter range Wolbachia still becomes fixed in the tsetse population at a prevalence close to 100%, but recombinant Sodalis becomes fixed at a lower prevalence between 84% (T.b. gambiense) or 87% (T.b. rhodesiense) and 0%. The HAT reproductive number is not reduced below one. When the probability of vertical transmission failure of recombinant Sodalis is less than 0.1%, approximately 30% of T.b. gambiense and 21% of T.b. rhodesiense HAT cases are averted (Fig 5). As the probability of vertical transmission failure is increased from 0% to 9.4%, the cumulative HAT cases averted drops to 1% for T.b. gambiense; when it is increased to 14.2%, the cumulative HAT cases averted drops to 3% for T.b. rhodesiense, indicating that HAT elimination is highly sensitive to the probability of recombinant Sodalis vertical transmission failure.
Global sensitivity analysis ranked the Wolbachia fecundity penalty as the most important model parameter for averting HAT cases. The analysis yielded a sensitivity index of 0.119 and PRCC of −0.716 (P < 0.001) for T.b. gambiense and a sensitivity index of 0.108 and PRCC of −0.733 (P < 0.001) for T.b. rhodesiense (Table 2). The remaining paratransgenesis parameters did not appreciably influence the percentage of HAT cases averted over 25 years, and had statistically significant PRCCs less than 0.25 and sensitivity indices equal to or less than 0.01 (Table 2). Therefore, ensuring that there is a low fecundity penalty for Wolbachia is paramount for HAT elimination to be achievable.
To investigate how the dynamics of Wolbachia and recombinant Sodalis impact HAT elimination via paratransgenesis, we modeled the dynamics of T.b. gambiense and T.b rhodesiense infection in humans, animals, and tsetse, while also incorporating the population dynamics of tsetse symbiotic bacteria Wolbachia and Sodalis into our model. We found that HAT elimination was highly dependent on thresholds for fitness penalties associated with paratransgenesis, inefficiencies in symbiont transmission, and tsetse migration. When these parameters were below their threshold values, Wolbachia and recombinant Sodalis became fixed in the tsetse population at a prevalence close to 100% over a period of 25 years, rendering the majority of the tsetse population resistant to trypanosome infection and thereby eliminating T.b. gambiense and T.b. rhodesiense cases. If either Wolbachia or recombinant Sodalis did not become fixed in the population at a prevalence high enough to reduce the reproductive number below one, as was the case when the thresholds for paratransgenesis parameters are exceeded, HAT was not eliminated. Furthermore, the thresholds for elimination did not vary by trypanosome species, despite differences between T.b. gambiense and T.b. rhodesiense regarding prevalence and duration of infection within humans and animals, as well as regarding vector preference for feeding on humans versus animals.
We found that fecundity and mortality penalties associated with Wolbachia colonization most influenced the successful fixation of paratransgenic tsetse and reduction in HAT cases. When these penalties are too high or vertical transmission from mother to offspring is not efficient, Wolbachia fails to serve as a driver of recombinant Sodalis into the tsetse population. The migration of wild type tsetse into the modeled population and paratransgenic tsetse out of the population also significantly impacted HAT elimination. When migration rates are too high, paratransgenic tsetse density is diluted by wild type tsetse, and HAT is not eliminated. The likelihood of HAT elimination is also sensitive to the fecundity and mortality penalties of recombinant Sodalis, as well as to vertical transmission probability. When penalties are too high or vertical transmission is inefficient, recombinant Sodalis becomes unlinked from Wolbachia vertical transmission, and paratransgenic tsetse fails to eliminate HAT. In addition, we determined parameter regions for which HAT elimination is not likely, but for which a reduction in incidence could be sustained. Specifically, when vertical transmission is between 99.9% and 90.6% (for T.b. gambiense) or 85.8% (for T.b. rhodesiense), recombinant Sodalis could become fixed in the tsetse population at a prevalence between 0% and 84% (T.b. gambiense) or 87% (T.b. rhodesiense) over the course of 25 years, thereby partially reducing cumulative T.b. gambiense HAT incidence between 30% and 1% and T.b. rhodesiense HAT incidence between 26% and 3%, respectively.
Although paratransgenesis has the potential to successfully eliminate HAT, the high sensitivity of Wolbachia and recombinant Sodalis prevalence to symbiont fitness penalties and tsetse migration rates indicates that these properties are fundamental to the effectiveness of paratransgenic approaches developed to curtail HAT. Given that HAT elimination is most sensitive to Wolbachia parameters, it will be essential to select a Wolbachia subspecies that has minimal, if any, fitness penalties in tsetse. Wolbachia infections are heterogeneous in natural populations, and prevalence has been found to vary from 0% to 100% [12, 24, 25]. In the laboratory, Wolbachia infections have been established in multiple tsetse species with a prevalence of 100% [12, 24, 25]. The successful elimination of HAT via paratransgenesis will not only necessitate the selection of Wolbachia species that have minimal fitness penalties in tsetse, but also tsetse species that are both well-suited to the ecology of targeted location and able to host a Wolbachia infection.
Moreover, it will also be critical to ensure that the recombinant Sodalis strain is transmitted from mother to offspring with a nearly 100% probability, and that it imposes only minor fecundity or mortality penalties. There is evidence that unmodified Sodalis alone may affect the fecundity or mortality of some tsetse species [14, 26, 27]. Of particular importance is the engineering of recombinant Sodalis to produce a molecule that effectively targets trypanosomes without simultaneously reducing the fitness of Sodalis. These characteristics of the selected Wolbachia strain and engineered recombinant Sodalis will need to be rigorously tested to ensure that HAT is successfully eliminated. If it becomes apparent that high vertical transmission probabilities for recombinant Sodalis cannot be achieved, the potential for partial reduction in HAT incidence will need to be investigated to determine if the benefit is nonetheless worth the cost of the intervention. Furthermore, if recombinant Sodalis transmission inefficiencies cause paratransgenic tsetse to be established at a prevalence in the population lower than the 84% or 87% required for elimination of T.b. gambiense or T.b. rhodesiense, respectively, it may be possible to time subsequent releases of paratransgenic flies—each using different subspecies of Wolbachia—to continue to drive recombinant Sodalis into the tsetse population. Finally, because migration rates may vary by location and tsetse species, paratransgenesis should be targeted to areas with low rates of tsetse migration. Low migration, combined with trapping of wild type flies prior to the intervention, maximizes the relative density of paratransgenic flies, ensuring the greatest number of HAT cases are averted while paratransgenic flies are prevalent, even if HAT elimination is not achieved.
Simulations were run using the Yale University Biomedical High Performance Computing Center, which is supported by NIH grants RR19895 and RR029676-01. We would like to thank both the Aksoy and Caccone Labs at Yale University for their expert feedback.
Conceived and designed the experiments: JAG JM JPT SA MNM APG. Performed the experiments: JAG JM JPT. Analyzed the data: JAG JM JPT. Contributed reagents/materials/analysis tools: JAG JM JPT. Wrote the paper: JAG JM JPT SA MNM APG.
- 1. World Health Organization. Control and surveillance of African trypanosomiasis. Report of a WHO Expert Committee. Geneva: World Health Organization, 1998.
- 2. World Health Organization. Human African trypanosomiasis: number of new cases drops to historically low level in 50 years 2010 [cited 2014 24 October 2014]. Available from: http://www.who.int/neglected_diseases/integrated_media/integrated_media_hat_june_2010/en/.
- 3. World Health Organization. Working to overcome the global impact of neglected tropical diseases. First WHO report on neglected tropical diseases. Geneva: World Health Organization, 2010.
- 4. World Health Organization. Human African trypanosomiasis (sleeping sickness): epidemiological update. Weekly Epidemiological Record. 2006;81(8):69–80.
- 5. Fevre EM, Picozzi K, Jannin J, Welburn SC, Maudlin I. Human African Trypanosomiasis: Epidemiology and Control. Adv Parisitol. 2006;61(167–221).
- 6. Pepin J, Meda HA. The epidemiology and control of human African trypanosomiasis. Advances in parasitology. 2001;49:71–132. pmid:11461032.
- 7. Brun R, Blum J, Chappuis F, Burri C. Human African trypanosomiasis. Lancet. 2010;375(9709):148–59. pmid:19833383.
- 8. Aksoy S. Control of tsetse flies and trypanosomes using molecular genetics. Veterinary parasitology. 2003;115(2):125–45. pmid:12878419.
- 9. Aksoy S, Maudlin I, Dale C, Robinson AS, O'Neill SL. Prospects for control of African trypanosomiasis by tsetse vector manipulation. Trends in parasitology. 2001;17(1):29–35. pmid:11137738.
- 10. Rio RV, Hu Y, Aksoy S. Strategies of the home-team: symbioses exploited for vector-borne disease control. Trends in microbiology. 2004;12(7):325–36. pmid:15223060.
- 11. Beard CB, O'Neill SL, Mason P, Mandelco L, Woese CR, Tesh RB, et al. Genetic transformation and phylogeny of bacterial symbionts from tsetse. Insect molecular biology. 1993;1(3):123–31. pmid:8269090.
- 12. Alam U, Medlock J, Brelsfoard C, Pais R, Lohs C, Balmand S, et al. Wolbachia symbiont infections induce strong cytoplasmic incompatibility in the tsetse fly Glossina morsitans. PLoS pathogens. 2011;7(12):e1002415. pmid:22174680; PubMed Central PMCID: PMC3234226.
- 13. Medlock J, Atkins KE, Thomas DN, Aksoy S, Galvani AP. Evaluating Paratransgenesis as a Potential Control Strategy for African Trypanosomiasis. PLoS Negl Trop Dis. 2013;7(8):e2374. pmid:23967363
- 14. Wamwiri FN, Alam U, Thande PC, Aksoy E, Ngure RM, Aksoy S, et al. Wolbachia, Sodalis and trypanosome co-infections in natural populations of Glossina austeni and Glossina pallidipes. Parasit Vectors. 2013;6(1):232. pmid:23924682; PubMed Central PMCID: PMC3751944.
- 15. Beard CB, Cordon-Rosales C, Durvasula RV. Bacterial symbionts of the Triatomine and their potential use in control of Chagas disease transmission. Annu Rev Entomol. 2002;47:123–41. pmid:11729071
- 16. Hurwitz I, Hillesland H, Fieck A, Das P, Durvasula R. The parantransgenic sand fly: a platform for control of Leishmania transmission. Parasit Vectors. 2011;19(4):82.
- 17. Riehle MA, Moreira CK, Lampe D, Lauzon C, Jacobs-Lorena M. Using bacteria to express and display anti-Plasmodium molecules in the mosquito midgut. International journal for parasitology. 2007;37:595–603. pmid:17224154
- 18. Chavshin AR, Oshaghi MA, Vantandoost H, Pourmand MR, Raeisi A, Enayati AA, et al. Identification of bacterial microflora in the midgut of the larvae and adult of wild caught Anopheles stephensi: a step toward finding suitable paratransgenesis candidates. Acta Trop. 2012;121:129–34. pmid:22074685
- 19. Rasgon JL. Using infections to fight infections: paratransgenic fungi can block malaria transmission in mosquitoes. Future Microbiol. 2011;6:851–3. pmid:21861618
- 20. Leak S. Tsetse Biology and Ecology: Their Role in the Epidemiology and Control of Trypanosomiasis. New York: CABI Publishing; 1999.
- 21. Kubi C. Susceptibility of the Tsetse Fly (Glossina Morsitans Morsitans) to Trypanosome Infections: Universiteit Gent; 2006.
- 22. Rio RV, Wu YN, Filardo G, Aksoy S. Dynamics of multiple symbiont density regulation during host development: tsetse fly and its microbial flora. Proc Biol Sci. 2006;273(1588):805–14. pmid:16618673; PubMed Central PMCID: PMC1560226.
- 23. Saltelli A, Ratto M, Andres T, Campolongo F, Cariboni J, Gatelli D, et al. Global Sensitivity Analysis: The Primer. West Sussex, England: John Wiley & Sons Ltd; 2008.
- 24. Doudoumis V, Alam U, Aksoy E, Abd-Alla AM, Tsiamis G, Brelsfoard C, et al. Tsetse-Wolbachia symbiosis: comes of age and has great potential for pest and disease control. J Invertebr Pathol. 2013;112 Suppl:S94–103. pmid:22835476; PubMed Central PMCID: PMC3772542.
- 25. Symula RE, Alam U, Brelsfoard C, Wu Y, Echodu R, Okedi LM, et al. Wolbachia association with the tsetse fly, Glossina fuscipes fuscipes, reveals high levels of genetic diversity and complex evolutionary dynamics. BMC Evol Biol. 2013;13:31. pmid:23384159; PubMed Central PMCID: PMC3574847.
- 26. Dennis JW, Durkin SM, Horsley Downie JE, Hamill LC, Anderson NE, MacLeod ET. Sodalis glossinidius prevalence and trypanosome presence in tsetse from Luambe National Park, Zambia. Parasit Vectors. 2014;7:378. pmid:25138709; PubMed Central PMCID: PMC4153904.
- 27. Wamwiri FN, Ndungu K, Thande PC, Thungu DK, Auma JE, Ngure RM. Infection with the secondary tsetse-endosymbiont Sodalis glossinidius (Enterobacteriales: Enterobacteriaceae) influences parasitism in Glossina pallidipes (Diptera: Glossinidae). J Insect Sci. 2014;14. pmid:25527583.
- 28. Rogers DJ. A general model for the African trypanosomiases. Parasitology. 1988;97:193–212. pmid:3174235
- 29. Artzrouni M, Gouteux JP. Control strategies for sleeping sickness in Central Africa: a model-based approach. Tropical medicine & international health: TM & IH. 1996;1(6):753–64. pmid:8980586.
- 30. Artzrouni M, Gouteux JP. A compartmental model of sleeping sickness in central Africa. J Biol Sys. 1996;4(4):459–77.
- 31. Chalvet-Monfray K, Artzrouni M, Gouteux JP, Auger P, Sabatier P. A two-patch model of Gambian sleeping sickness: application to vector control strategies in a village and plantations. Acta biotheoretica. 1998;46(3):207–22. pmid:10220868.
- 32. Habtemariam T, Ruppanner R, Riemann HP, Theis JH. An Epidemiologic Systems Analysis Model for African Trypanosomiasis. Prev Vet Med. 1982/1983;1:125–36.
- 33. Habtemariam T, Ruppanner R, Riemann HP, Theis JH. Epidemic and Endemic Characteristics of Trypanosomiasis in Cattle: A Simulation Model. Prev Vet Med. 1982/1983;1:137–45.
- 34. Muller G, Grebaut P, Gouteux JP. An agent-based model of sleeping sickness: simulation trials of a forest focus in southern Cameroon. Comptes rendus biologies. 2004;327(1):1–11. pmid:15015750.
- 35. McDermott JJ, Coleman PG. Comparing apples and oranges—model-based assessment of different tsetse-transmitted trypanosomosis control strategies. International journal for parasitology. 2001;31(5–6):603–9. pmid:11334949.
- 36. Milligan PJ, Baker RD. A model of tsetse-transmitted animal trypanosomiasis. Parasitology. 1988;96 (Pt 1):211–39. pmid:3362578.
- 37. Trail JC, Murray M, Sones K, Jibbo JM, Durkin J, Light D. Boran cattle maintained by chemoprophylaxis under trypanosomiasis risk. J Agric Sci. 1985;105(1):147–66.
- 38. Baker RD. Modelling trypanosomiasis prevalence and periodic epidemics and epizootics. IMA journal of mathematics applied in medicine and biology. 1992;9(4):269–87. pmid:1302761.
- 39. Clausen PH, Adeyemi I, Bauer B, Breloeer M, Salchow F, Staak C. Host preferences of tsetse (Diptera: Glossinidae) based on bloodmeal identifications. Medical and veterinary entomology. 1998;12(2):169–80. pmid:9622371.
- 40. Negash M, Girma M, Seyoum E. Epizootiological importance of Glossina morsitans submorsitans (Diptera: Glossinidae) (Newstead) in the Ghobe River Valley, Southwest Ethiopia. Acta Trop. 2007;102(2):100–5. pmid:17543265
- 41. Muturi CN, Ouma JO, Malele II, Ngure RM, Rutto JJ, Mithofer KM, et al. Tracking the Feeding Patterns of Tsetse Flies (Glossina Genus) by Analysis of Bloodmeals Using Mitochonrdrial Cytochromes Genes. PLoS One. 2011;6(2):e17284. pmid:21386971
- 42. Njiokou F, Simo G, Mbida Mbida A, Truc P, Cuny G, Herder S. A study of host preference in tsetse flies using a modified heteroduplex PCR-based method. Acta Trop. 2004;91:117–20. pmid:15234660
- 43. Simo G, Njiokou F, Mbida Mbida A, Njitchouang G, Herder S, Asonganyi T, et al. Tsetse fly host preference from sleeping sickness foci in Cameroon: Epidemiological implications. Infection, Genetics and Evolution. 2008;8:34–9. pmid:17977803
- 44. Waiswa C, Picozzi K, Katunguka-Rwakishaya E, Olaho-Mukani W, Musoke R, Welburn S. Glossin fuscipes fuscipes in the trypanosomiasis endemic areas of south eastern Uganda: Apparent density, trypanosome infection rates and host feeding preferences. Acta Trop. 2006;99:23–9. pmid:16870129
- 45. Checchi F, Filipe JA, Haydon DT, Chandramohan D, Chappuis F. Estimates of the duration of the early and late stage of gambiense sleeping sickness. BMC infectious diseases. 2008;8:16. pmid:18261232; PubMed Central PMCID: PMC2259357.